Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis.

Skapinakis P, Caldwell DM, Hollingworth W, Bryden P, Fineberg NA, Salkovskis P, Welton NJ, Baxter H, Kessler D, Churchill R, Lewis G.

Lancet Psychiatry. 2016 Aug;3(8):730-9. doi: 10.1016/S2215-0366(16)30069-4. Epub 2016 Jun 16.

2.

Patient-reported outcomes in obsessive-compulsive disorder.

Subramaniam M, Soh P, Ong C, Esmond Seow LS, Picco L, Vaingankar JA, Chong SA.

Dialogues Clin Neurosci. 2014 Jun;16(2):239-54. Review.

3.

Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Katzman MA, Bleau P, Blier P, Chokka P, Kjernisted K, Van Ameringen M; Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University., Antony MM, Bouchard S, Brunet A, Flament M, Grigoriadis S, Mendlowitz S, O'Connor K, Rabheru K, Richter PM, Robichaud M, Walker JR.

BMC Psychiatry. 2014;14 Suppl 1:S1. doi: 10.1186/1471-244X-14-S1-S1. Epub 2014 Jul 2. Review.

4.

Obsessive compulsive disorder.

Soomro GM.

BMJ Clin Evid. 2012 Jan 18;2012. pii: 1004. Review.

5.

Obsessive-compulsive spectrum disorders.

Allen A, King A, Hollander E.

Dialogues Clin Neurosci. 2003 Sep;5(3):259-71.

6.

Current management of obsessive and phobic states.

Goljevscek S, Carvalho LA.

Neuropsychiatr Dis Treat. 2011;7:599-610. doi: 10.2147/NDT.S17032. Epub 2011 Sep 30.

7.

Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder.

Bloch MH, McGuire J, Landeros-Weisenberger A, Leckman JF, Pittenger C.

Mol Psychiatry. 2010 Aug;15(8):850-5. doi: 10.1038/mp.2009.50. Epub 2009 May 26.

8.

A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.

Simpson HB, Foa EB, Liebowitz MR, Ledley DR, Huppert JD, Cahill S, Vermes D, Schmidt AB, Hembree E, Franklin M, Campeas R, Hahn CG, Petkova E.

Am J Psychiatry. 2008 May;165(5):621-30. doi: 10.1176/appi.ajp.2007.07091440. Epub 2008 Mar 3.

9.

Escitalopram in obsessive-compulsive disorder: a case series.

Zutshi A, Math SB, Reddy YC.

Prim Care Companion J Clin Psychiatry. 2007;9(6):466-7. No abstract available.

10.

Contemporary assessment and pharmacotherapy of Tourette syndrome.

Scahill L, Erenberg G, Berlin CM Jr, Budman C, Coffey BJ, Jankovic J, Kiessling L, King RA, Kurlan R, Lang A, Mink J, Murphy T, Zinner S, Walkup J; Tourette Syndrome Association Medical Advisory Board: Practice Committee..

NeuroRx. 2006 Apr;3(2):192-206. Review.

Supplemental Content

Support Center